Cargando…
Reflections on 2015
The Editor-in-Chief reflects on recent advances, including CRISPR technology and the expansion of immunotherapy, and highlights trends that will be important in the coming year.
Autor principal: | Chabner, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746097/ https://www.ncbi.nlm.nih.gov/pubmed/26786261 http://dx.doi.org/10.1634/theoncologist.2016-0005 |
Ejemplares similares
-
While We’re at It, Let’s Whack the FDA
por: Chabner, Bruce A.
Publicado: (2016) -
Understanding the Precision in “Precision Medicine”
por: Chabner, Bruce A.
Publicado: (2016) -
Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
por: Chabner, Bruce A.
Publicado: (2010) -
New Results Will Change the Paradigm for Phase I Trials and Drug Approval
por: Chabner, Bruce A.
Publicado: (2010) -
Does Chemotherapy Induce Metastases?
por: Chabner, Bruce A.
Publicado: (2018)